acyclovir
- Product NDC
- 70934-697
- 11-digit product format
- 709340697
- Labeler code
- 70934
- Product ID
- 70934-697_aa54be1d-392d-895f-e053-2a95a90a19d9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- acyclovir
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Apotex Corp.
- Application
- ANDA077309
- Marketing category
- ANDA
- Marketing start
- 2020-05-08
- Marketing end
- 0000-00-00
- Substance
- ACYCLOVIR
- Active strength
- 800 mg/1
- Pharmacologic classes
- DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 70934-697-35 | 70934069735 | 35 TABLET in 1 BOTTLE, PLASTIC (70934-697-35) | 35 tablet | 2020-05-08 | 0000-00-00 | No | No | Current |
| 70934-697-70 | 70934069770 | 70 TABLET in 1 BOTTLE, PLASTIC (70934-697-70) | 70 tablet | 2020-05-12 | 0000-00-00 | No | No | Current |